I am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression.
For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com
For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com